NCT05440006View on ClinicalTrials.gov

A Study of Food Effect on the Pharmacokinetics of Fuzuloparib Capsules in Chinese Healthy Adult Subjects

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

July 3, 2022

Primary Completion Date

July 20, 2022

Study Completion Date

July 20, 2022

Conditions

Solid Tumor

Interventions

DRUG

Fuzuloparib

Fuzuloparib Capsules; 150mg; single dose per cycle.

Trial Locations (1)

241000

Wannan Medical College Yijishan Hospital, Wuhu

All Listed Sponsors

lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY